These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17085024

  • 1. A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products.
    Schellekens RC, Stuurman FE, van der Weert FH, Kosterink JG, Frijlink HW.
    Eur J Pharm Sci; 2007 Jan; 30(1):15-20. PubMed ID: 17085024
    [Abstract] [Full Text] [Related]

  • 2. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.
    Christensen LA.
    Dan Med Bull; 2000 Feb; 47(1):20-41. PubMed ID: 10709142
    [Abstract] [Full Text] [Related]

  • 3. Impairment of the in vitro drug release behaviour of oral modified release preparations in the presence of alcohol.
    Fadda HM, Mohamed MA, Basit AW.
    Int J Pharm; 2008 Aug 06; 360(1-2):171-6. PubMed ID: 18547758
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model.
    Klein S, Stein J, Dressman J.
    J Pharm Pharmacol; 2005 Jun 06; 57(6):709-19. PubMed ID: 15969925
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.
    Fadda HM, Merchant HA, Arafat BT, Basit AW.
    Int J Pharm; 2009 Dec 01; 382(1-2):56-60. PubMed ID: 19666093
    [Abstract] [Full Text] [Related]

  • 11. A clinical trial on absorption and N-acetylation of oral and rectal mesalazine.
    Dilger K, Trenk D, Rössle M, Cap M, Zähringer A, Wacheck V, Remmler C, Cascorbi I, Kreisel W, Novacek G.
    Eur J Clin Invest; 2007 Jul 01; 37(7):558-65. PubMed ID: 17576207
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
    Jantratid E, De Maio V, Ronda E, Mattavelli V, Vertzoni M, Dressman JB.
    Eur J Pharm Sci; 2009 Jun 28; 37(3-4):434-41. PubMed ID: 19491035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.